- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Skyepharma Share News (SKP)
Share News for Skyepharma (SKP)
| Share Price: 53.25 | Bid: 52.00 | Ask: 54.25 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
SkyePharma launches extended-release zileuton asthma drug ZYFLO in US
LONDON (Thomson Financial) - SkyePharma PLC and its US marketing partner, Critical Therapeutics Inc have announced the US launch of ZYFLO CR, th[27 Sep '07]
Skyepharma H1 pretax loss narrows; sees H2 sales similar to H1 UPDATE
(Updates with expenses and outlook details) LONDON (Thomson Financial) - Skyepharma PLC reported a narrower first-half pretax loss on lower[20 Sep '07]
Skyepharma H1 comes in ahead of expectations; FDA meeting in October UPDATE
(Recast, adds CEO, analyst comment) LONDON (Thomson Financial) - Skyepharma PLC said that it will have an October meeting with the FDA to di[20 Sep '07]
Skyepharma H1 pretax loss narrows; sales down 8 pct; sees H2 sales similar to H1
LONDON (Thomson Financial) - Skyepharma PLC reported a narrower first-half pretax loss, and said it continues to have confidence in the potentia[20 Sep '07]
Skyepharma, FDA agree approach for further study on Flutiform efficacy
LONDON (Thomson Financial) - Skyepharma PLC said it has agreed with the US Food and Drug Administration on an approach for the additional clinic[11 Sep '07]
Skyepharma says US FDA has accepted application for new Sular formulation UPDATE
(partially rewritten opening paras, adds context) LONDON (Thomson Financial) - Drug maker Skyepharma PLC and Sciele Pharma Inc said the US F[5 Sep '07]
Skyepharma says US FDA has accepted application for new Sular formulation
LONDON (Thomson Financial) - Drug maker Skyepharma PLC and Sciele Pharma Inc said the US Food & Drug Administration (FDA) has accepted the suppl[5 Sep '07]
Sciele Pharma gets FDA acceptance for sNDA on Sular using Skyepharma technology
LONDON (Thomson Financial) - Sciele Pharma Inc said the US Food & Drug Administration has accepted the supplemental New Drug Application (sNDA)[4 Sep '07]
